Relationship between apoptosis regulator proteins (bcl-2 and p53) and Gleason score in prostate cancer

Pathology and Oncology Research

Volumn 7, Issue 3, 2001, Pages 209-212

  Paker, Semra Karaburun ^a   Kilicarslan, Bahar ^a   Ciftcioglu, Akif M ^a   Oztekin, Sevim ^a   Sargin, Figen C ^a   Erdogru, Tibet ^a   Baykara, Mehmet ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Apoptosis; Bcl 2; P53; Prostate cancer

Indexed keywords

PROTEIN BCL 2; PROTEIN P53; TUMOR PROTEIN;

ADENOCARCINOMA; AGED; APOPTOSIS; ARTICLE; CANCER STAGING; COMPARATIVE STUDY; DISEASE COURSE; ENZYME IMMUNOASSAY; HUMAN; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; PROSTATE TUMOR; RETROSPECTIVE STUDY;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; APOPTOSIS; DISEASE PROGRESSION; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; PROGNOSIS; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; RETROSPECTIVE STUDIES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0035236455     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03032351     Document Type: Article

References (5)

1. Bauer JJ, Sesterhenn IA, Mostofi FK, et al: Elevated levels of apoptosis regulator proteins p53 and bcl-2 are independent prognostic biomarkers in surgically treated clinically localized prostate cancer. J Urol 156:1511-1516, 1996.
2. Boring CC, Squires T: Cancer statistics 1994. CA Cancer J Clin 44:7, 1994.
3. Bubendorf L, Sauter G, Moch H, et al: Prognostic significance of bcl-2 in clinically localized prostate cancer. Am J Pathol 148:1557, 1996.
4. Cheng L, Leibovich BC, Bergstralh EJ, et al. P53 Alteration in regional lymph node metastases from prostate carcinoma. Cancer 85:2455-2459, 1999.
5. Cheng L, Sebo JT, Pisansky T, et al: P53 Protein Overexpression Is Associated with Increased Cell Proliferation in Patients with Locally Recurrent Prostate Carcinoma after Radiation Therapy. Cancer 85:1293-1299, 1999.